Considerations of germline testing in prostate cancer screening.

Published

Journal Article

Prostate cancer screening remains controversial in the medical field. While screening men above 50 years can impose overdiagnosis and overtreatment, targeted screening of males with pathologic variants of genetic mutations is evolving and viewed as sensible. Identifying such patients requires genetic testing in males having family history of prostate cancer or certain ethnicity. Such strategies will likely occur as routine practice once favorable results of ongoing studies assessing genetic predisposition are released.

Full Text

Duke Authors

Cited Authors

  • Polascik, TJ; Orabi, H

Published Date

  • October 2019

Published In

Volume / Issue

  • 26 / 5 Suppl 2

Start / End Page

  • 46 - 47

PubMed ID

  • 31629431

Pubmed Central ID

  • 31629431

International Standard Serial Number (ISSN)

  • 1195-9479

Language

  • eng

Conference Location

  • Canada